ResMed Inc. (RSMDF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 09:48AM EDT
| Previous Close | 17.70 |
| Open | 17.70 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 17.70 - 17.70 |
| 52 Week Range | 13.72 - 22.46 |
| Volume | |
| Avg. Volume | 18 |
| Market Cap | 26.979B |
| Beta (5Y Monthly) | 0.67 |
| PE Ratio (TTM) | 29.50 |
| EPS (TTM) | 0.60 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.19 (1.08%) |
| Ex-Dividend Date | Feb 07, 2024 |
| 1y Target Est | 11.49 |
ZacksCompared to Estimates, ResMed (RMD) Q3 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for ResMed (RMD) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
GuruFocus.comResMed Inc (RMD) Q3 Fiscal 2024 Earnings: Surpasses Analyst Expectations with Strong Growth
Comprehensive Analysis of ResMed's Latest Financial Performance
ZacksResMed (RMD) Q3 Earnings and Revenues Surpass Estimates
ResMed (RMD) delivered earnings and revenue surprises of 10.94% and 1.90%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.